HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giovanni Selvaggi Selected Research
Giovanni Selvaggi Research Topics
Disease
19
Neoplasms (Cancer)
02/2024 - 06/2004
18
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 07/2002
7
Lung Neoplasms (Lung Cancer)
01/2022 - 07/2003
5
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 06/2008
4
Adenocarcinoma
05/2018 - 05/2002
3
Fatigue
02/2024 - 03/2016
3
Exanthema (Rash)
01/2022 - 01/2020
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2009 - 05/2002
2
Disease Progression
02/2024 - 07/2003
2
Diarrhea
02/2024 - 03/2016
2
Brain Neoplasms (Brain Tumor)
11/2021 - 01/2020
2
Neoplasm Metastasis (Metastasis)
01/2020 - 12/2005
2
Carcinoma (Carcinomatosis)
07/2003 - 05/2002
1
Thymoma (Thymic Carcinoma)
02/2024
1
Edema (Dropsy)
01/2023
1
Hemorrhage
01/2022
1
Leukopenia
01/2022
1
Lymphopenia (Lymphocytopenia)
01/2022
1
Neuroblastoma
11/2021
1
Hyperbilirubinemia
01/2021
1
Melanoma (Melanoma, Malignant)
01/2017
1
Nausea
03/2016
1
Myalgia
03/2016
1
Anorexia
03/2016
1
Febrile Neutropenia
03/2016
1
Arthralgia (Joint Pain)
03/2016
1
Neutropenia
03/2016
1
Vomiting
03/2016
1
Pancreatic Neoplasms (Pancreatic Cancer)
07/2015
1
Malignant Mesothelioma
03/2010
1
Hematologic Neoplasms (Hematological Malignancy)
01/2008
1
Ovarian Neoplasms (Ovarian Cancer)
02/2006
1
Rheumatoid Arthritis
02/2006
1
Parasitic Diseases (Parasitic Disease)
02/2006
1
Mesothelioma
02/2006
1
Large Cell Carcinoma
05/2002
Drug/Important Bio-Agent (IBA)
6
ensartinib
IBA
02/2024 - 01/2020
6
Nivolumab
IBA
02/2024 - 01/2018
6
Platinum
IBA
01/2021 - 07/2003
5
Anaplastic Lymphoma Kinase
IBA
02/2024 - 01/2021
4
Proteins (Proteins, Gene)
FDA Link
02/2024 - 05/2002
4
Crizotinib
IBA
02/2024 - 01/2020
4
Alanine Transaminase (SGPT)
IBA
02/2024 - 01/2020
4
Gemcitabine
FDA Link
05/2018 - 07/2003
4
Carboplatin (JM8)
FDA Link
Generic
01/2017 - 01/2005
4
Pemetrexed (MTA)
FDA Link
03/2010 - 01/2005
3
Immune Checkpoint Inhibitors
IBA
02/2024 - 01/2018
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2024 - 05/2006
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
02/2024 - 01/2020
3
Ipilimumab
IBA
01/2021 - 01/2018
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2017 - 11/2009
3
ErbB Receptors (EGF Receptor)
IBA
03/2016 - 06/2004
3
Thymidylate Synthase
IBA
03/2010 - 02/2006
2
Tyrosine Kinase Inhibitors
IBA
02/2024 - 11/2021
2
vorolanib
IBA
02/2024 - 01/2022
2
Folic Acid Antagonists
IBA
01/2008 - 02/2006
1
Programmed Cell Death 1 Receptor
IBA
02/2024
1
Platelet-Derived Growth Factor
IBA
02/2024
1
cyclopropapyrroloindole
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
Circulating Tumor DNA
IBA
01/2021
1
alectinib
IBA
01/2021
1
Amylases
FDA Link
01/2020
1
Transferases
IBA
01/2020
1
Steroids
IBA
01/2020
1
ceritinib
IBA
01/2020
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Lipase (Acid Lipase)
FDA Link
01/2020
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2017
1
Electrolytes
IBA
03/2016
1
Caspase 3 (Caspase-3)
IBA
07/2015
1
Bevacizumab (Avastin)
FDA Link
11/2009
1
Gefitinib (Iressa)
FDA Link
11/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2009
1
Etoposide (VP 16)
FDA Link
Generic
06/2008
1
Proteinase-Activated Receptors
IBA
05/2006
1
Antibodies
IBA
05/2006
1
raltitrexed (D 1694)
IBA
02/2006
1
Antimetabolites
IBA
02/2006
1
Diphosphonates (Bisphosphonates)
IBA
12/2005
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2005
1
Nucleotides
IBA
06/2004
1
Cisplatin (Platino)
FDA Link
Generic
07/2003
1
Biotin (Vitamin H)
FDA Link
05/2002
1
Avidin
IBA
05/2002
Therapy/Procedure
11
Drug Therapy (Chemotherapy)
02/2024 - 07/2002
9
Therapeutics
01/2021 - 06/2004
1
Activities of Daily Living (ADL)
10/2005
1
Induction Chemotherapy
07/2003